Results in research may vary
Common contraindications cited in the research-use community include: anyone with active or recent cancer (BPC-157 and TB-500 promote angiogenesis), people with Wilson's disease or other copper-metabolism disorders (GHK-Cu component), anyone pregnant or breastfeeding (no safety data), and athletes subject to WADA testing (BPC-157 and TB-500 are prohibited)
A few years later, in 2004 and 2006, other researchers [9,76] supplemented the previously published study with new results that additionally pointed to the positive effect of the peptide in reducing the physiological and behavioral negative effects triggered by acute or chronic alcohol consumption
B.GojkovicS.KrezicI.MalekinusicD.ZizekH.VuleticL
74 , 48894897 (2008) Sakoulas, G
How Long a KLOW Vial Lasts A reconstituted 80mg vial at 40mg/mL holds 200 units of solution (2mL 100 units/mL)